We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Patient-derived organoids of non-small cells lung cancer and their application for drug screening.
- Authors
LI, Y. F.; GAO, Y.; LIANG, B. W.; CAO, X. Q.; SUN, Z. J.; YU, J. H.; LIU, Z. D.; HAN, Y.
- Abstract
The article examines patient-derived non-small cells lung cancer (NSCLC) organoids (PDO) and their drug screening applications. Also cited are the possible use of PDOs in personalized cancer therapy, the creation of living NSCLC organoids biobank, and the anticancer activities of the natural compounds chelerythrine chloride, harmine, and cantharidin.
- Subjects
ORGANOIDS; NON-small-cell lung carcinoma; DRUG use testing; CANCER patients; CANCER treatment; INDIVIDUALIZED medicine
- Publication
Neoplasma, 2020, Vol 67, Issue 1, p1
- ISSN
0028-2685
- Publication type
Article
- DOI
10.4149/neo_2019_190417N346